Ubiquitin (Ub) conjugation is an essential post-translational modification that affects nearly all proteins in eukaryotes. The functions and mechanisms of ubiquitination are areas of extensive and ongoing study, and yet the dynamics and regulation of even free (i.e., unconjugated) Ub are poorly understood. A major impediment has been the lack of simple and robust techniques to quantify Ub levels in cells and to monitor Ub release from conjugates. Here we describe the development of avidity-based fluorescent sensors that address this need. The sensors bind specifically to free Ub, have K d values down to 60 pM, and, in concert with a newly developed workflow, allow us to distinguish and quantify the pools of free, protein-conjugated, and thioesterified forms of Ub from cell lysates. Alternatively, free Ub in fixed cells can be visualized microscopically by staining with a sensor. Real-time assays using the sensors afford unprecedented flexibility and precision to measure deubiquitination of virtually any (poly)Ub conjugate.
Introduction
In ubiquitination, free Ub is activated by formation of a C-terminal thioester first with an E1 Ub-activating enzyme and then an E2 Ub-conjugating enzyme before it is transferred to substrates, usually to form an isopeptide bond with a protein lysine ε-amine 1 .
Deubiquitinating enzymes (DUBs) can disassemble Ub-protein conjugates and recycle Ub; thus, cells contain three classes of Ub: free, thioester-activated, and (iso)peptide conjugated. Because ubiquitination contributes to the regulation of nearly every cellular process, the availability of free Ub needs to be tightly controlled to maintain cell fitness.
Mechanisms contributing to Ub homeostasis include its expression as Ub-protein fusions with ribosome subunits and as polyubiquitin, processing of these precursors to generate free monoUb, and finally recycling from Ub-protein conjugates by DUBs 2 .
Perturbations of these processes can deplete cellular free Ub and cause defects in cell development or neuronal functions [2] [3] [4] [5] [6] [7] [8] [9] and inhibit proliferation in several cancer cell lines 10, 11 . Conversely, transgenic mice that overexpress Ub by just 2 or 3-fold exhibit neurological abnormalities 12 .
Although the need to maintain and regulate intracellular free Ub is now well established, studies of Ub levels have been hampered by the lack of reagents for specific and quantitative measurements of distinct Ub pools. One approach to monitor intracellular Ub has been ectopic expression of GFP-tagged versions of Ub 13 , but interpretations of results from such experiments can be compromised by perturbations to the regulation of endogenous Ub and non-physiological behavior of the tagged Ub. Typically, to quantify endogenous free, conjugated, or total Ub, anti-Ub antibodies in conjunction with ELISA or SDS-PAGE and immunoblotting are used. However, with respect to sensitivity and reliability of quantitation, those approaches have major drawbacks. For example, due to the extremely high structural diversity of polyUb and Ub-protein conjugates 14 , even with monoclonal anti-Ub antibodies, binding efficiencies will vary among the many different forms of Ub in cell lysates. Moreover, particularly with quantitation by western blots, dynamic range is inherently very limited and reproducibility can be difficult to achieve.
More recently, Ub Protein Standard Absolute Quantification (Ub-PSAQ) mass spectrometry (MS) has been described to quantify free and conjugated Ub from cell lysates 15 . However, this method does not resolve the pool of thioester-activated Ub, and its dependence on sophisticated instrumentation and sequential affinity-based isolation steps makes it challenging to implement for most laboratories. Finally, none of the aforementioned approaches to Ub quantitation are amenable to real-time measurements of free Ub concentrations as they change, for example, during enzymecatalyzed deubiquitination reactions.
With the dual goals of having a simple, reliable method to quantify cellular Ub pools and a sensitive and versatile real-time DUB assay, we embarked on development of sensors for free Ub detection and quantitation. To distinguish the free, activated, and conjugated Ub pools, we developed protocols to convert either thioesterified or (iso)peptideconjugated Ub into free Ub for subsequent quantitation with a sensor reagent. To engineer the sensors, our general strategy was to fuse genetically two or three Ub binding domains (UBDs) of known structure that bind to non-overlapping Ub surfaces, and to exploit avidity effects to achieve high affinity and selectivity. To convert the binding proteins into sensors, we attached fluorescent dyes whose intensity changed in response to binding by free Ub. We demonstrate that the sensors provide convenient means to (i) measure free, activated, and conjugated intracellular Ub; (ii) quantify deubiquitination of unlabeled (poly)Ub-protein conjugates in real-time DUB assays; and (iii) localize and quantify endogenous free Ub by fluorescence microscopy of fixed cells.
Results

Design and characterization of the sensors
The free Ub sensors were developed to have high affinity and selectivity for free Ub and report binding events via a strategically placed fluorophore. Our design strategy was to assemble Ub binding proteins from multiple UBDs linked in tandem; peptide linkers were kept to a minimum length in order to promote avidity while minimizing the entropic cost of binding. Most UBDs bind Ub through interactions with one of three different surfaces: the Ub hydrophobic patch surrounding residue I44, the Ub C-terminal tail, and the surface around D58 (Fig. 1a , upper panel). Individually, UBDs bind Ub with only modest affinity (K d = 10 -5 to 10 -3 M), but by linking two or three weak-binding UBDs that target distinct Ub surfaces, we expected that high affinity could be achieved overall. An early version of such an avidity-based binder that we call tIVR employed IsoT Buz , Vps27 UIM , and Rabex5 Ruz domains fused in tandem with flexible peptide linkers ( Fig. 1a , lower left panel and Supplementary Fig. S1 ). The IsoT Buz domain (K d = 3 µM for Ub) 16 , which binds primarily to residues at the Ub C-terminus, conferred selectivity for free Ub, whereas the Vps27 UIM (K d = 117 µM) 17 and Rabex5 Ruz (K d = 12 µM) 18, 19 domains worked synergistically with IsoT Buz to increase overall affinity and specificity for Ub.
To measure the affinity between tIVR and free Ub, we first titrated a fluorescent Ub derivative (Atto532-Ub(S20C); see Methods) with tIVR and determined a 0.4 nM K d based on an observed 3.5-fold fluorescence decrease upon formation of the 1:1 complex ( Supplementary Fig. S2a ). Then, by taking advantage of the high affinity and fluorescence intensity change of Atto532-Ub(S20C) upon binding to tIVR, we determined tIVR affinities for Ub and other ligands by use of competition binding assays ( Fig. 1b ). We found that free Ub binds to tIVR with a K d of 19 nM (measured as a K i ; Fig.   1b ); the nearly 50-fold stronger binding of Atto532-Ub(S20C) indicates that the Atto532 dye contributes favorably (ΔG ~ -0.2 kcal/mol) to the interaction with tIVR. The competition assays additionally showed that tIVR has high selectivity against the Ub-like (UbL) protein Nedd8 and against Ub derivatives that lack a free C-terminal carboxylate ( Fig. 1b) . Among the many different UbL proteins found in eukaryotes 20 , Nedd8 is most similar to Ub in its sequence and tertiary structure, and its C-terminal four amino acids are identical 21 ; nonetheless, tIVR has a 3000-fold preference for Ub. A similarly large discrimination was observed against Ub-GB1, a mimic of a Ub-protein conjugate in which the Ub C-terminus is extended by the Protein G 56-amino acid B1 domain, and even addition of the small adduct hydrazine to the Ub C-terminus decreased tIVR affinity 150-fold relative to free Ub (Fig. 1b ).
In order to provide the sensor with a direct readout of Ub binding, we explored sitespecific labeling with fluorescent dyes ( Supplementary Fig. S3 ). We found that tIVR modified with Atto532-maleimide on C130 showed a 3-fold fluorescence increase upon Ub binding ( Supplementary Fig. S2b ). By replacing the Vps27 UIM with the S5a UIM domain and introducing two amino acid substitutions in the IsoT Buz domain ( Fig. 1a and Supplementary Fig. S1 ), we developed a second-generation sensor, tISR, that binds to free Ub nearly 10-times tighter than tIVR ( Supplementary Fig. S2c,d ). Atto532-labeled tISR showed a 6-fold fluorescence increase upon binding of free Ub, but the fluorophore reduced affinity for Ub so that Atto532-labeled tISR and unlabeled tIVR showed similar K d values of 24.3 nM and 25.4 nM, respectively (Fig. 1c,e and Supplementary Fig. S2b ).
A third generation of free Ub sensor was developed with the goal of achieving even greater affinity. Ubiquilin-1 UBA (UQ1 UBA ) was used to replace the tIVR/tISR UIM because of its relatively tight binding to the Ub hydrophobic patch (K d = 22 µM) 22,23 and we predicted that a shorter linker (2 amino acids versus 5 with tIVR or tISR) could be used to connect the UQ1 UBA C-terminus with the N-terminus of IsoT Buz . The shorter linker was expected to reduce the entropic cost of complex formation. We conjugated Atto532 to UQ1 UBA G573C in tUI ( Fig. 1a , lower right panel); titration with free Ub revealed a 3-fold increase in fluorescence and a remarkably low K d of 66 pM ( Fig. 1d,e ).
In an independent experiment, we measured the association and dissociation rate constants for the Atto532-tUI-Ub complex from which we calculated a K d of 56.4 ± 1.2 pM ( Supplementary Fig. S4 ), which is in excellent agreement with the results from titrations done at equilibrium. To our knowledge, this very high affinity is unprecedented for binding to a single Ub. Atto532-tUI showed exceptional selectivity against Ub Cterminal conjugates, having a binding preference for free Ub over Ub-GB1 of >10 6 . With respect to discrimination of Ub from UbL proteins, Atto532-tUI has 120-fold higher affinity for Ub than Nedd8. The substantially higher selection against Nedd8 seen with the tIVR and tISR sensors can be attributed to the Ruz domain, which is absent in tUI.
Nonetheless, as described below, tUI's selectivity coupled with its exceptional affinity make it the first choice for most in vitro applications.
The results above demonstrated the high selectivity of sensors engineered to bind Ub that has a free C-terminus. In cells, multiple forms of Ub can fulfill that criterion; most notably, the proximal Ub in a "free" or "unanchored" polyUb chain would have its Cterminal amino acids available for binding by the sensor Buz domain. Inspection of the sites on Ub used for Ub-Ub linkages in polyUb (i.e., Ub's seven lysine ε-amines plus the α-amine on M1) showed that they are not occluded when bound by the various UBDs used in the sensors (Fig. 1a ). These models are consistent with studies that have shown little or no discrimination by individual UBA, UIM, or Buz domains for binding Ub in chains with different Ub-Ub linkages 16, 22, 23 . Accordingly, competition by Ub 2 or Ub 4 linked through M1, K6, K29, K33, K48, or K63 revealed little difference among them or from free monoUb in binding to tIVR ( Fig. 1e ,f). Although not tested directly, based on previous findings of linkage-independent binding of UBA domains 22, 23 and the small tUI footprint modeled onto Ub (Fig. 1a ), we anticipate similar linkage-independent binding by tUI to unanchored polyUb.
Another modification to Ub that potentially could affect detection by the sensors is phosphorylation. Multiple serine and threonine phosphosites have been found on Ub 24 ;
as with Ub lysines, most of these do not show overlap with the surfaces bound by our sensor UBDs (Fig. 1a ). Ub phosphorylation on S65, which has functions in Ub-mediated signaling and mitophagy in particular, has been the most intensively studied phosphoUb species [25] [26] [27] [28] . When we titrated Atto532-tUI with Ub(pS65) we determined a K d of 262 pM ( Fig. 1d,e ), indicating 4-fold weaker binding than with Ub. Wauer et al. have shown by NMR that Ub(pS65) exists in an equilibrium between two principal conformers 29 . The major form (~70%) is essentially like unmodified Ub, whereas in the minor conformer (~30%) movement of the β5 strand retracts the normally-extended C-terminal residues into the body of Ub and displaces a key component of the hydrophobic patch. Because interactions with Buz and UBA domains are likely to be disrupted in the minor Ub(pS65) conformer, we expect that tUI would bind tightly only to the major conformer; thus, the Ub versus Ub(pS65) K d difference could in part reflect the equilibrium where only a fraction of Ub(pS65) is in the binding-competent conformation.
Real-time deubiquitination assays with label-free substrates
Quantitative activity assays are essential to understand the regulations and specificities of DUBs. Typically physiological substrates of DUBs are not used in quantitative assays due to limited availability and lack of good methods to quantify products. Moreover, real-time monitoring of activity -the preferred approach to high-precision kinetics studieshas been virtually impossible with physiological DUB substrates. For these reasons, artificial Ub derivatives such as Ub-(7-amido-4-methylcoumarin) or Ub-protein conjugates (e.g., diUb) with pairs of fluorophores that enable FRET-based assays are used 30, 31 . Our free Ub sensors now make it possible to develop less restrictive DUB assays that could employ virtually any Ub conjugate as a substrate. As an example, we used Atto532-tIVR to monitor DUB-catalyzed release of free Ub (or unanchored polyUb) in a continuous fluorometric assay. For a model substrate, we used K48-linked Ub 5 conjugated to the N-terminus of ovomucoid first domain (OM); to provide a second means to assay reactions, the OM moiety was modified with Lucifer Yellow dye (LY) to facilitate detection after SDS-PAGE 32 . For the DUB, we used human OTUB1, which selectively cleaves K48 Ub-Ub isopeptide linkages 33 and is activated allosterically by interaction with certain E2 enzymes 34 . Without OTUB1, Ub 5 OM(LY) and Atto532-tIVR showed no fluorescence change, whereas enzyme addition initiated a fluorescence increase indicating release of free (poly)Ub (Fig. 2 ). Furthermore, in agreement with the report by Wiener et al. 34 Supplementary Fig. S5d ).
Ub pool quantitation in cell lysates
We next developed methods that use the sensors to quantify cellular Ub pools. Our goal was to generate a workflow for routine measurements that would not depend on expensive, time-intensive steps requiring chromatography and mass spectrometry to separate and detect different Ub populations. The general approach, in which the sensor (e.g., Atto532-tUI) fluorescence is measured with and without addition of cell lysate or other sample, promised to be simple and direct. The main challenge was to develop conditions to prevent appearance of free Ub due to disassembly of conjugates by endogenous DUBs or from spontaneous hydrolysis of Ub thioesters.
Our strategy was to lyse cells and quickly inactivate endogenous DUBs and other proteases (see Methods) and then treat each sample in three ways to differentially convert Ub pools to the free-Ub form for measurement with the sensor (Fig. 3a) . In order to measure endogenous free Ub without interference from chemically-labile Ub thioesters, samples were treated with hydrazine to rapidly and selectively convert all Ub thioesters into Ub C-terminal hydrazide; Ub-hydrazide is stable and, relative to free Ub, gives a negligible response with the sensor (Fig. 1b-e and Supplementary Fig. S6 ).
Thus, sensor fluorescence of a hydrazine-treated sample will measure endogenous free Ub. With a second portion of the sample, β-mercaptoethanol was used to release Ub from Ub thioesters; measurement with the sensor then will report the sum of the endogenous free and thioester Ub pools 35 . A third portion was incubated with Usp2cc, a truncated DUB that can deubiquitinate virtually all forms of conjugated Ub 36 ; when used in combination with a thiol reducing agent, all forms of Ub in the sample are converted to free Ub and the sensor readout will report the total Ub. By deducting the sum of the activated and free Ub from the total Ub, we can determine the amount of Ub that had been in (poly)Ub-proteins or other conjugates.
These assays were first used to quantify the amounts of free, activated, and conjugated Ub in HeLa cells (Fig. 3) ; the results are in good agreement with other reports 15, 37, 38 .
The sensor assays then were used with HeLa cells after treatment with inhibitors of the E1 Ub-activating enzyme or proteasome (Fig. 3b,c) . As expected 39 , the E1 inhibitor Compound 1 (C1) dramatically increased free Ub with a concomitant loss of activated Ub and most Ub-protein conjugates (Fig. 3b ). Conversely, proteasome inhibition by bortezomib (BTZ) promoted accumulation of Ub conjugates that reached a maximum at 1 h and then persisted through a 4 h treatment ( Fig. 3c ; Supplementary Fig. S7 ). The conjugate increase was accompanied by a modest depletion of activated Ub and a twofold decrease in free Ub, presumably due to impaired proteasome-dependent recycling of Ub from conjugates. Different from this result, proteasome-inhibited MEF cells exhibited little change in free Ub levels, even though conjugated Ub increased 50%; instead, the total amount of Ub increased, likely due to increased expression of Ub genes 40 .
Quantitation of endogenous free Ub in fixed cells
We realized that Atto532-tUI, with its high affinity and specificity for free Ub and conjugated fluorophore, could be an ideal tool to localize endogenous, intracellular free Ub. Initially, fixed cells were stained directly with Atto532-tUI, but high background fluorescence, most likely from nonspecific binding by the fluorophore, reduced sensitivity (data not shown). Therefore, we used instead a hemagglutinin-tagged version of tUI (HA-tUI) followed by detection with an anti-HA antibody. We confirmed the specificity of HA-tUI for free Ub by performing control experiments where fixed cells were incubated with HA-tUI together with excess free Ub. The fluorescence observed in these competition experiments was negligible, suggesting that the staining with HA-tUI is specific for cellular Ub (Supplementary Fig. S8 ). A diffuse intracellular distribution of free Ub was expected based on its small size (8.6 kDa) and negligible self-association 41 .
Staining with HA-tUI was observed throughout the cytoplasm and nucleus in HeLa, U2OS, MEF and RPE1 cell lines (Fig. 4a ). Compared to K48-linked chains and monoand polyubiquitylated proteins, free Ub staining is evenly distributed through the whole cell ( Supplementary Fig. S9 ). GFP-Ub that had been mutated to prevent its conjugation to other proteins was similarly diffuse when expressed in mammalian cells 13 .
Staining with HA-tUI offers an alternative to solution-based assays to monitor changes in free Ub during growth or in response to different stresses. After proteasome inhibition by incubation with BTZ for 1 h, HeLa, U2OS, MEF and RPE1 cells showed decreased staining with HA-tUI based on their 1.3 to 1.5-fold lower anti-HA antibody fluorescence relative to control (i.e., vehicle only) cells. As expected, E1 inhibition increased the free Ub (2-fold in MEF and RPE cells, and 3-fold in HeLa and U2OS cells) (Fig. 4b,c ).
Although proteasome inhibition decreased free Ub staining in all four cell lines, the intracellular distributions of free Ub appeared unaffected. For RPE1 cells, ratios of cytoplasmic to nuclear staining were not changed significantly by incubation with BTZ (control cells, 0.85 ± 0.07, n = 5; BTZ, 0.89 ± 0.08, n = 4). In contrast to the results with BTZ, increased staining was observed after E1 inhibition and cell-to-cell variability was greater overall (Fig. 4a-c) . The average changes in staining of HeLa cells are consistent with the in-solution assays, whereas for MEF cells the staining showed ~25% less free Ub after proteasome inhibition than was determined from the in-solution assays (Figs. 3c and 4a-c). Possibly, because hydrazine treatment was not used with the imaged cells, some of the free Ub detected by staining could have originated from spontaneous hydrolysis of the Ub-thioester pool, thereby inflating the "free" Ub and confounding direct comparison of the two assays. The staining with tUI also revealed cell-cycle dependent differences in free Ub levels. RPE1 cells undergoing mitosis showed a 1.6fold increase in tUI staining compared with interphase cells (Fig. 4d ). The increase in free Ub may be due, at least in part, to the large-scale deubiquitination of H2A histones observed for mitotic cells 42 .
Discussion
Individually, most UBDs have only modest affinity for Ub and are typically found together with other binding domains (and sometimes additional UBDs) to promote binding to specific types of polyUb or Ub-protein conjugates. From genetic fusions of multiple UBDs, we have engineered new proteins with specificity and extremely high affinity for monomeric free Ub. Our basic strategy was to use the Buz domain to direct binding to Ub with an unconjugated C-terminus, and to increase affinity with one or two additional UBDs that interact with Ub on non-overlapping surfaces. A critical aspect of the design strategy was to maximize the effect from avidity. This was achieved by having multiple UBDs bind simultaneously and by minimizing the entropy lost upon complex formation through careful selection of peptides linking the UBDs. Avid binding can boost affinity by combining the contributions of individual binding domains in a complex assembled from a multivalent ligand and a corresponding multivalent binder.
The Gibbs free energy for binding overall (ΔG total ) can be approximated as the sum of the individual binding domain (BD) interaction free energies (ΔG BD1 , ΔG BD2 , etc.) plus the unfavorable free energy due to reduction in entropy (predominantly, losses in translational and rotational entropy) from having all the binding domains linked together (ΔG S ) 43 :
(1) ΔG total = ΔG BD1 + ΔG BD2 ···· + ΔG BDn + ΔG S To achieve "perfect" avid binding and maximize affinity, ΔG S should be close to zero.
For Ub binding by a tandem-UBD (tUBD) protein such as tIVR, we can write: (2) ΔG tUBD = ΔG UBD1 + ΔG UBD2 + ΔG UBD3 + ΔG S ΔG UBD can be calculated for each UBD based on the K d values reported for Ub binding by the individual IsoT Buz , Vps27 UIM , and Rabex5 Ruz domains (i.e., -7.53, -5.25, and -6.62 kcal·mol -1 , respectively); similarly, ΔG tIVR = -10.52 kcal·mol -1 can be calculated from the tIVR-Ub K d of 19.3 nM (Fig. 1e ). Thus, although avidity promotes tight binding by tIVR, it's at the cost of ΔG S , which is (-10.52) -(-19.40) = 8.88 kcal·mol -1 . This substantial penalty reduced tIVR affinity by >10 6 from a theoretical K d of 5.9 x 10 -15 M.
Remarkably, tUI's affinity for Ub (K i = 194 pM; Supplementary Fig. S10 ) is only 3-times weaker than what would be predicted for perfect avid binding by the combination of the UQ1 UBA domain (K d = 22 µM) 22,23 and the Buz domain (K d = 3 µM) 16 . Contributing to the much greater efficiency of avidity seen with tUI relative to tIVR is that tUI has only one linker peptide (versus two in tIVR), and its linker is very short ( Supplementary Fig. S1 ).
Thus, a likely route to increase affinity for tIVR or tISR is further optimization of the interdomain linkers. On the other hand, a large increase in affinity by tUI would have to come from tighter-binding versions of one or both of its UBDs, as the linker peptide already is nearly optimum.
There are several ways in which our tUBD binders for free Ub could be improved in affinity or for specific applications. Affinity might be increased, as noted above, with either modified linkers or alternative UBDs. Our designs have utilized only a few of more than 20 types of UBDs 44, 45 ; moreover, other Ub binding proteins such as catalyticallyinactive DUBs might be used as components of tUBD-type fusion constructs 46 .
Particularly intriguing is the prospect of tailoring recognition by incorporation of a UBD that would select either for or against specific modifications on the Ub. For example, although tIVR binds equally well to free polyUb chains of different Ub-Ub linkage types ( Fig. 1f) Additionally, extracellular free Ub has been suggested as a biomarker for trauma and disease 48 ; here, the free Ub sensors can replace the less specific antibody-based assays typically used to quantify extracellular Ub. Ultimately, we envision that the free Ub binders and the fluorescent sensors developed from them will provide effective tools to capture, deplete, quantify, or visualize free Ub in vitro and in cells. were purchased from UbiQ Bio (Amsterdam), Ub(pS65) was from BostonBiochem (Cambridge, MA), and M1-linked Ub 4 was prepared as described 51 .
Methods
Synthesis of Ub-hydrazide
Ub (1.5 mM) was incubated with 10 mM ATP, 10 mM MgCl 2 , 100 mM sodium 2mercaptoethanesulfonate (MESNA; Fluka), and 100 nM mouse E1 in 20 mM HEPES (pH 8.0) for 3 h at 37 °C to form Ub-MESNA thioester (confirmed by mass spectrometry;
see Supplementary Fig. S6b ). The Ub-MESNA then was incubated in 300 mM aqueous hydrazine for 30 min at 37 °C to form Ub-hydrazide. The reaction product was diluted 25-fold with 50 mM ammonium acetate, adjusted to pH 4.5 (Buffer B), and purified by cation-exchange chromatography on a Mono S column (GE Healthcare, 17-0547-01).
The column was washed with 20 volumes of Buffer B and eluted with a linear gradient of 0 -1 M NaCl in the same buffer. The purified Ub-hydrazide was confirmed by mass spectrometry ( Supplementary Fig. S6b ).
Fluorophore labeling
Sensor proteins were labeled at cysteine with fluorophore-maleimide dyes from ATTO-TEC GmbH (Atto dyes; see Supplementary Fig. S3 ), Molecular Probes (Alexa Fluor 488), or Anaspec (fluorescein). Fluorophore-maleimide dyes (1.5 to 5-fold molar excess)
were incubated with 50 µM sensor in 50 mM HEPES, pH 7.4, 100 mM NaCl for 2 h at 25 °C. Excess dyes were quenched by incubation with 10 mM β-mercaptoethanol for 10 min at 25 °C. To remove excess dyes, the reaction product was bound to Ni-NTA resin (Thermo Fisher) equilibrated with Buffer A, the resin was washed 5 times with the Histrap binding buffer, and sensor proteins were eluted with Histrap elution buffer.
Labeling was confirmed by SDS-PAGE and then scanning the gel for fluorescence using a Typhoon FLA 9500 (GE Healthcare Life Sciences). Degree of labeling (DOL) and concentrations of the labeled proteins were calculated by the equations below.
In the equations, A m represents the absorbance at the dye absorption maximum, A 280 is absorbance at 280 nm of the labeled protein, ε prot is the extinction coefficients at 280 nm of the protein, ε 280 is the extinction coefficient at 280 nm of the dye alone, ε m is the extinction coefficient at the absorption maximum of the dye, and CF 280 is the correction factor at 280 nm.
Binding assays
All binding assays were done in PBS buffer, pH 7.4, supplemented with 0.05% Brij35 and either 0.2 mg/ml ovalbumin or GB1 protein, and either 1 mM DTT or 1 mM TCEP. A FluoroMax-4 spectrofluorimeter (HORIBA Scientific) was used to measure fluorescence intensity in the binding assays. K d and K i values were calculated by fitting with a singlesite binding model 52 using Prism 6 (GraphPad Software). Because Atto532-tUI has exceptionally high affinity for Ub, 10 pM Atto532-tUI was used in the binding assays to keep its concentration below the K d for Ub. To improve detection of the fluorescence from this low concentration of Atto532-tUI, we increased the assay volume to 2.7 ml.
The stock Ub titrated into the solution was ≤ 1.5% of the total volume.
Stopped flow kinetics
To determine the k off and k on rates of Atto532-tUI with free Ub, rapid kinetics were monitored by fluorescence using a MOS-500 spectrometer equipped with a SFM-4000 mixer (Bio-Logic Science Instruments) maintained at 25 °C. The excitation wavelength was set to 530 nm with a 5 nm bandwidth, and the fluorescence emission was detected with a 540-620 nm bandpass filter. 
Real-time DUB assays
Sample preparation for microscopy
HeLa, U2OS, and MEF cells were cultured in DMEM (Gibco) supplemented with 10%
(v/v) FBS and 100 U/mL penicillin and 100 ug/mL streptomycin (Hyclone Autofluorescence intensities recorded from unstained cells were subtracted from the tUI-fluorescence.
Three-dimensional reconstructions of RPE-1 cells were obtained with Imaris software (version 9.1.1, Bitplane AG) from serial z-sections acquired at 0.242 µm increments.
The Imaris surface creation tool was used to generate volume renderings and to quantify tUI fluorescence intensities in both interphase and mitotic cells.
Statistical Analysis
Statistical calculations were performed with GraphPad Prism software and are described in the relevant figure legends. P values less than 0.05 were considered significant. 
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